Eli Lilly and Company (LLY) closed at $1,115.25 on September 12, 2026, marking a 0.71% decline over the prior 24 hours. The move extended a broader retreat that has weighed on the stock across multiple timeframes.
Over the past seven days, shares have fallen 2.92%, and the 30-day loss now stands at 8.62%. The sustained pullback has drawn down the stock considerably from levels seen a month ago, though Eli Lilly remains one of the most valuable companies in the pharmaceutical sector.
The company's market capitalization stood at $1,000.99 billion as of the close, keeping it just above the $1 trillion threshold. The figure reflects the scale of investor exposure to any continued price movement in either direction.
Friday's session added to a pattern of gradual erosion in LLY's share price over the past month, with no single-session move accounting for the bulk of the decline. The stock's performance over the 30-day window represents the most pronounced pressure visible in the available data.
